0442 GMT - The length of Pro Medicus's new contracts is seen as good news at RBC Capital Markets. Analyst Jackson Lee reminds investors that TidalHealth agreed to a seven-year contract, and that Allegheny stuck to a five-year term for its renewal. He writes in a note to clients that the duration of both represents a step forward in debunking the widespread narrative over AI disruption. Lee writes that neither company has shown signs of seeking a shorter-term contract, which would have kept open the option of exploring AI native alternatives. RBC has a sector-perform rating and A$195.00 target price on the stock, which is up 8.1% at A$142.95. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
June 01, 2026 00:42 ET (04:42 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.